Evidence map›Paper›PMID 32305291›Full record

ArticleJournal of hepatology2020

Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury.

Xiaolong Qi, Chuan Liu, Zicheng Jiang, Ye Gu, Guo Zhang, Chuxiao Shao, Hongmei Yue, Zhenhuai Chen, Baoyi Ma, Dengxiang Liu and 16 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Autoimmune liver diseases and SARS-CoV-2.World journal of gastroenterology · 2023
    Review
  16. Impact of baseline abnormal liver enzymes in the outcome of COVID-19 infection.Translational gastroenterology and hepatology · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Xiaolong QiCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China. Electronic address: qixiaolong@vip.163.com.
Chuan LiuCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Zicheng JiangCHESS-COVID-19 Group, Ankang Central Hospital, Ankang, China.
Ye GuCHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang, Shenyang, China.
Guo ZhangCHESS-COVID-19 Group, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Chuxiao ShaoCHESS-COVID-19 Group, Zhejiang University Lishui Hospital & Lishui Central Hospital, Lishui, China.
Hongmei YueDepartment of Respiratory and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou, China.
Zhenhuai ChenDepartment of Respiratory Medicine, The People's Hospital of Baoding, Baoding, China.
Baoyi MaDepartment of Respiratory Medicine, The People's Hospital of LinXia Hui Prefecture, Linxia, China.
Dengxiang LiuCHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, China.
Lin ZhangHepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Jitao WangCHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, China.
Dan XuCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Junqiang LeiCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Xun LiThe First Hospital of Lanzhou University, Lanzhou, China.
Huihong HuangCHESS-COVID-19 Group, Ankang Central Hospital, Ankang, China.
Yan WangCHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang, Shenyang, China.
Hongyan LiuCHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang, Shenyang, China.
Jie YangCHESS-COVID-19 Group, Zhejiang University Lishui Hospital & Lishui Central Hospital, Lishui, China.
Hongqiu PanDepartment of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China.
Weiying LiuDepartment of Respiratory and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou, China.
Wenjuan WangCHESS-COVID-19 Group, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Fujian LiDepartment of Respiratory Medicine, The People's Hospital of Baoding, Baoding, China.
Shengqiang ZouDepartment of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China.
Hongguang ZhangDepartment of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China.
Jiahong DongHepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. Electronic address: dongjh_btch@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralBetacoronavirusChinaCOVID-19HumansLiverSARS-CoV-2

Identifiers

PMID32305291
PMCPMC7162763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.